Neuroscience News

Crossover episode in which Nicholas Weiler & Michael Osborne discuss the life of cosmologist Stephen Hawking

New tools that reveal how neuron-specific waves travel through the brains of mice in real time hold promise for understanding diseases such as epilepsy and Alzheimer’s, and open avenues for advances in neuroscience and AI.

The Global Neurodegeneration Proteomics Consortium gathered a trove of data on potential signs of neurological disease—and researchers including Knight Initiative director Tony Wyss-Coray are already using it to make new discoveries.

Is your brain aging faster than your chronological age? New research shows it could raise your risk of death and dementia significantly—and offers promise for early intervention.

An interdisciplinary team of Wu Tsai Neuro scientists working on balls of human neurons called organoids wanted to scale up their efforts and take on important new questions. The solution was all around them.

Knight Initiative-funded research ran the gamut from chemistry to public health, but one theme brought it all together: Studying what makes the brain resilient will help more people live better lives.

Knight Initiative researchers developed a blood test that track the biological age of the brain and other organs.

Stanford neurobiologist Carla Shatz, famous for discovering how neural connections develop early in life, is using that knowledge to work on the problem of how they can later deteriorate from Alzheimer’s disease.

The findings of two recent studies give hope that the disease could one day be reversed in humans—but experts warn that this complex disease will likely need multiple complementary treatments.

In which addiction expert Keith Humphreys explains how neuroscience is reshaping our understanding of substance abuse—and why policy still hasn’t caught up.

With support from a Wu Tsai Neuro grant, researchers have developed a potentially game-changing new way to treat a leading cause of death.

A new Stanford study used blood proteins to analyze the 'biological' age of brains and other organs compared to the person's actual age.

The tool, built by a team led by Stanford's Tony Wyss-Coray, uses a single vial of blood to assess the 'biological age' of each organ.

A blood-test analysis developed at Stanford Medicine can determine the “biological ages” of 11 separate organ systems in individuals’ bodies and predict the health consequences.

Research in mice indicates that inhibiting the LRRK2 enzyme could stabilize patients with a type of Parkinson’s disease.

Former Wu Tsai Neuro Interdisciplinary Postdoctoral Scholar Sergey Stavisky helped lead an effort to translate brain signals into speech.